Alnylam Pharmaceuticals (United States) — United States
Medicine · Health Sciences
17h-index2.0kcitations21works0.02yr avg
Accepting Students?
No reports yet. Know if this professor is taking students?
Research Topics
Parkinson's Disease Mechanisms and Treatments(7), Nuclear Receptors and Signaling(7), Pluripotent Stem Cells Research(4), Nicotinic Acetylcholine Receptors Study(4), Neuroscience and Neuropharmacology Research(3)
Publications21 total
Neurology·2020· 75 citedOpen Access
Neurobiology of Disease·2019· 79 citedOpen Access
Neurobiology of Disease·2019· 72 citedOpen Access
Human Molecular Genetics·2019· 162 citedOpen Access
Oxford University Research Archive (ORA) (University of Oxford)·2019Open Access
Stem Cell Reports·2017· 56 citedOpen Access
Trends in Neurosciences·2017· 631 citedOpen Access
2017· 1 citedOpen Access
Human Molecular Genetics·2016· 74 citedOpen Access
Stem Cells Translational Medicine·2016· 49 citedOpen Access
Stem Cell Reports·2016· 350 citedOpen Access
Vanderbilt University Press eBooks·2015· 3 cited
Drug Development Research·1998· 33 cited
Archives of Neurology·1996· 74 cited
PubMed·1989· 57 citedOpen Access
Population Studies·1984· 17 cited
Neuroscience & Biobehavioral Reviews·1981· 96 cited
Journal of Neuroscience Research·1980· 43 cited
Acute and chronic effects of nicotine in rats and evidence for a noncholinergic site of action.
PubMed·1979· 9 cited
page 1 of 2Next →
Frequent Co-authors
Richard Wade‐Martins(8), Jane Vowles(7), Sally A. Cowley(7), Leo G. Abood(4), Warren D. Hirst(3), Charmaine Lang(3), Joshua Shulman(3), Caleb Webber(3), Natalie Connor‐Robson(3), Cathy Browne(3), Hugo J. R. Fernandes(2), Brent J. Ryan(2), Samuel Evetts(2), Federico Zambon(2), Rory Bowden(2), Alexandre Guerreiro(2), Eric D. Caine(2), Jeffrey G. Martin(2), Benbo Gao(2), Kejie Li(2)